Contreras Johanna, Nussbaum Jeremy, Cangialosi Peter, Thapi Sahityasri, Radakrishnan Ankitha, Hall Jillian, Ramesh Prashasthi, Trivieri Maria Giovanna, Sandoval Alejandro Folch
Division of Heart Failure and Cardiac Transplantation, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
J Clin Med. 2024 Jan 4;13(1):285. doi: 10.3390/jcm13010285.
Minoritized racial and ethnic groups suffer disproportionately from the incidence and morbidity of pulmonary hypertension (PH), as well as its associated cardiovascular, pulmonary, and systemic conditions. These disparities are largely explained by social determinants of health, including access to care, systemic biases, socioeconomic status, and environment. Despite this undue burden, minority patients remain underrepresented in PH research. Steps should be taken to mitigate these disparities, including initiatives to increase research participation, combat inequities in access to care, and improve the treatment of the conditions associated with PH.
少数族裔群体在肺动脉高压（PH）的发病率和患病率以及与之相关的心血管、肺部和全身疾病方面承受着不成比例的负担。这些差异很大程度上可由健康的社会决定因素来解释，包括获得医疗服务的机会、系统性偏见、社会经济地位和环境。尽管负担过重，但少数族裔患者在PH研究中的代表性仍然不足。应采取措施减轻这些差异，包括采取举措增加研究参与度、消除获得医疗服务方面的不平等现象，以及改善与PH相关疾病的治疗。
